Pfizer Inc
(MIL:1PFE)
€
25
-0.395 (-1.56%)
Market Cap: 140.28 Bil
Enterprise Value: 192.77 Bil
PE Ratio: 36.11
PB Ratio: 1.64
GF Score: 63/100 Pfizer Inc at JPMorgan US All-Stars Conference (Virtual) Transcript
Sep 16, 2020 / 05:00PM GMT
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon and evening, everybody. I'm Chris Schott, pharma analyst here at JPMorgan. And it's my pleasure today to be hosting a fireside chat with Albert Bourla, the Chairman and CEO of Pfizer. First of all, Albert, thanks so much for joining us today.
Albert Bourla
Pfizer Inc. - Chairman of the Board & CEO
Thank you for having us, Chris. It's a great opportunity for me to talk to the investors.
Questions & Answers
Christopher Thomas Schott;Albert Bourla
JPMorgan Chase & Co, Research Division - Senior Analyst;
Great. Well, maybe just to kick off. I know we're coming off a 2-day analyst meeting the company hosted earlier this week. And to me, that really highlighted both the growth in the core portfolio as well as the company's emerging pipeline. So maybe just as an opening question. What were the key takeaways you'd like to highlight to investors coming out of that event?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot